Spots Global Cancer Trial Database for Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer
Official Title: Open, Single-Arm Phase II Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer Expressing the Estrogen and/or Progesterone Receptor
Study ID: NCT00210028
Conditions
Study Description
Brief Summary: The purpose of this study is to evaluate the objective response rate when ZARNESTRA is added to treatment with tamoxifen
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Institut Bergonie, Bordeaux, , France
Institut Val d'Aurelle_ Paul Lamarque, Montpellier, , France
Institut Claudius Regaud, Toulouse, , France
Contact Details
Name: Henri Roché, Pr
Affiliation: Institut Claudius Regaud
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
